Krystal Biotech, Inc. Form 8-K Filing

Krystal Biotech, Inc. announced that Kirti Ganorkar has resigned from the Board of Directors, effective December 31, 2025. Mr. Ganorkar's resignation is due to time constraints resulting from increased responsibilities after his promotion to Managing Director at Sun Pharma. His departure is not a result of any disagreements with the Board or management. The Board expressed gratitude for his service since the company's public debut in September 2017. The filing also includes standard cover page interactive data as an exhibit. The report was signed by Krish S. Krishnan, Chairman and CEO, on December 23, 2025.